Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
暂无分享,去创建一个
Chuan Qin | Yanfeng Yao | Cun Li | Dong Wang | Dong Yang | K. To | Jian-Piao Cai | J. Chan | K. Yuen | Jie Zhou | Zhongshan Cheng | H. Chu | Cun Li | Bosco Ho-Yin Wong | C. Qin | B. Zheng | M. Yeung | Kwok-Yung Yuen | Jasper Fuk-Woo Chan | W. Ho | Dong Yang | Bo-Jian Zheng | Man-Lung Yeung | Hin Chu | Jie Zhou | Jian-Piao Cai | Kelvin Kai-Wang To | Yanfeng Yao | Ivy Hau-Yee Chan | A. Lee | Zhong-Shan Cheng | Andrew Chak-Yiu Lee | Chuangen Li | Wai-Kuen Ho | Dong Wang | I. Chan | Chuangen Li | Hin Chu
[1] V. Cheng,et al. Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection , 2007, Clinical Microbiology Reviews.
[2] R. Baric,et al. Rapid generation of a mouse model for Middle East respiratory syndrome , 2014, Proceedings of the National Academy of Sciences.
[3] Jian-Piao Cai,et al. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset , 2015, The Journal of infectious diseases.
[4] Kwok-Hung Chan,et al. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. , 2013, The Journal of general virology.
[5] R. Favory,et al. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases , 2014, Journal of Clinical Virology.
[6] M. Buchmeier,et al. Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines , 2012, mBio.
[7] B. Cowling,et al. Incubation period as part of the case definition of severe respiratory illness caused by a novel coronavirus. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[8] H. Chu,et al. Tetherin/BST-2 is essential for the formation of the intracellular virus-containing compartment in HIV-infected macrophages. , 2012, Cell host & microbe.
[9] R. Pebody,et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[10] Herman Tse,et al. Interspecies transmission and emergence of novel viruses: lessons from bats and birds , 2013, Trends in Microbiology.
[11] K. To,et al. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? , 2012, Journal of Infection.
[12] Lisa E. Gralinski,et al. Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus , 2013, mBio.
[13] Michael G. Katze,et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques , 2013, Proceedings of the National Academy of Sciences.
[14] D. Swerdlow,et al. Clinical and Laboratory Findings of the First Imported Case of Middle East Respiratory Syndrome Coronavirus to the United States , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Colin Adrain,et al. Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis* , 2001, The Journal of Biological Chemistry.
[16] T. Bestebroer,et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment , 2013, The Journal of general virology.
[17] K. To,et al. Development and Evaluation of Novel Real-Time Reverse Transcription-PCR Assays with Locked Nucleic Acid Probes Targeting Leader Sequences of Human-Pathogenic Coronaviruses , 2015, Journal of Clinical Microbiology.
[18] C. Morimoto,et al. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Osterhaus,et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.
[20] V. Brown,et al. Replication and Shedding of MERS-CoV in Upper Respiratory Tract of Inoculated Dromedary Camels , 2014, Emerging infectious diseases.
[21] Jincun Zhao,et al. T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice , 2010, Journal of Virology.
[22] C. Morimoto,et al. Bilateral Entry and Release of Middle East Respiratory Syndrome Coronavirus Induces Profound Apoptosis of Human Bronchial Epithelial Cells , 2013, Journal of Virology.
[23] D. Dwyer,et al. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets , 2005, International Journal of Infectious Diseases.
[24] M. Müller,et al. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection , 2013, Virology Journal.
[25] S. Elmore. Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.
[26] C. Morimoto,et al. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. , 1991, Journal of immunology.
[27] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[28] Jincun Zhao,et al. Evasion by Stealth: Inefficient Immune Activation Underlies Poor T Cell Response and Severe Disease in SARS-CoV-Infected Mice , 2009, PLoS pathogens.
[29] C. Morimoto,et al. CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] K. To,et al. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus , 2013, Journal of Infection.
[31] M. Koopmans,et al. Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[32] K. Yuen,et al. Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response , 2014, Journal of Virology.
[33] Christian Drosten,et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[34] Xinxia Peng,et al. Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset , 2014, PLoS pathogens.
[35] Z. Memish,et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study , 2013, The Lancet Infectious Diseases.
[36] M. Titécat,et al. Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside? , 2014, PloS one.
[37] K. To,et al. Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis , 2013, The Journal of infectious diseases.
[38] K. To,et al. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response , 2014, Virology.
[39] Christian Drosten,et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.
[40] Susanna K. P. Lau,et al. Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease , 2015, Clinical Microbiology Reviews.
[41] Xin Geng,et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection , 2013, Nature.
[42] Honglin Chen,et al. An Animal Model of MERS Produced by Infection of Rhesus Macaques With MERS Coronavirus , 2013, The Journal of infectious diseases.
[43] V. Cheng,et al. Sensitive and Specific Monoclonal Antibody-Based Capture Enzyme Immunoassay for Detection of Nucleocapsid Antigen in Sera from Patients with Severe Acute Respiratory Syndrome , 2004, Journal of Clinical Microbiology.
[44] Y. Guan,et al. Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.
[45] Zhongbin Chen,et al. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease. , 2014, The Journal of general virology.
[46] F. Weber,et al. Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist , 2013, Journal of Virology.
[47] Noha H Farag,et al. Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] Thomas O. Metz,et al. Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses , 2014, mBio.
[49] J. Sung,et al. Detection of SARS coronavirus in plasma by real-time RT-PCR. , 2003, The New England journal of medicine.
[50] K. To,et al. Differential Cell Line Susceptibility to the Emerging Novel Human Betacoronavirus 2c EMC/2012: Implications for Disease Pathogenesis and Clinical Manifestation , 2013, The Journal of infectious diseases.
[51] Yang Yang,et al. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists , 2013, Protein & Cell.